ATE276749T1 - Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung - Google Patents

Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung

Info

Publication number
ATE276749T1
ATE276749T1 AT00973658T AT00973658T ATE276749T1 AT E276749 T1 ATE276749 T1 AT E276749T1 AT 00973658 T AT00973658 T AT 00973658T AT 00973658 T AT00973658 T AT 00973658T AT E276749 T1 ATE276749 T1 AT E276749T1
Authority
AT
Austria
Prior art keywords
symptoms
compositions
preventing
flu
treating cold
Prior art date
Application number
AT00973658T
Other languages
English (en)
Inventor
Paul John Rennie
Simon Phillip King
Kimberly Ann Biedermann
Jeffrey Michael Morgan
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE276749T1 publication Critical patent/ATE276749T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208—Tissues; Wipes; Patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H21/00—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties
    • D21H21/14—Non-fibrous material added to the pulp, characterised by its function, form or properties; Paper-impregnating or coating material, characterised by its function, form or properties characterised by function or properties in or on the paper
    • D21H21/36—Biocidal agents, e.g. fungicidal, bactericidal, insecticidal agents
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
    • D21H27/00—Special paper not otherwise provided for, e.g. made by multi-step processes
    • D21H27/30—Multi-ply
    • D21H27/32—Multi-ply with materials applied between the sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Pest Control & Pesticides (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
AT00973658T 1999-10-19 2000-10-19 Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung ATE276749T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42113199A 1999-10-19 1999-10-19
PCT/US2000/028856 WO2001028556A2 (en) 1999-10-19 2000-10-19 Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use

Publications (1)

Publication Number Publication Date
ATE276749T1 true ATE276749T1 (de) 2004-10-15

Family

ID=23669286

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973658T ATE276749T1 (de) 1999-10-19 2000-10-19 Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung

Country Status (21)

Country Link
EP (2) EP1225887A2 (de)
JP (2) JP2003512325A (de)
KR (2) KR20020042729A (de)
CN (3) CN1411372A (de)
AT (1) ATE276749T1 (de)
AU (2) AU777549B2 (de)
BR (1) BR0014778A (de)
CA (2) CA2382985A1 (de)
CZ (1) CZ20021374A3 (de)
DE (1) DE60014163T2 (de)
ES (1) ES2223601T3 (de)
HK (1) HK1050475A1 (de)
HU (1) HUP0204123A3 (de)
MX (1) MXPA02003882A (de)
NO (1) NO20021830L (de)
NZ (1) NZ518117A (de)
PL (1) PL199782B1 (de)
RU (1) RU2228177C2 (de)
TR (1) TR200201048T2 (de)
WO (2) WO2001028552A2 (de)
ZA (1) ZA200202475B (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050232868A1 (en) * 1999-10-19 2005-10-20 The Procter & Gamble Company Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
US20020172656A1 (en) 2000-01-20 2002-11-21 Biedermann Kimberly Ann Cleansing compositions
AU2001234509A1 (en) * 2000-01-20 2001-07-31 The Procter And Gamble Company Antimicrobial compositions
DE10065045A1 (de) * 2000-12-23 2002-07-04 Beiersdorf Ag W/O-Emulsionen mit einem Gehalt an einem oder mehreren Ammoniumacryloyldimethyltaurat/Vinylpyrrolidoncopolymeren
JP4681132B2 (ja) * 2001-01-29 2011-05-11 味の素株式会社 一酸化窒素合成酵素産生促進剤および化粧料若しくは医薬組成物
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
JP4318899B2 (ja) * 2001-08-27 2009-08-26 第一三共ヘルスケア株式会社 抗感冒剤
JP2009132734A (ja) * 2001-08-27 2009-06-18 Daiichi Sankyo Healthcare Co Ltd 抗感冒剤
DE10144235B4 (de) * 2001-09-08 2004-08-19 Beiersdorf Ag W/S-Emulsionen und deren Verwendung
US20030118620A1 (en) * 2001-09-12 2003-06-26 Unilever Home & Personal Care Usa, Division Of Conopco Inc. Thickener system for cosmetic compositions
US6806213B2 (en) 2001-12-20 2004-10-19 Kimberly-Clark Worldwide, Inc. Disposable wash cloth and method of using
DK1532974T3 (da) 2002-03-12 2009-05-11 Galderma Res & Dev Sammensætning, der omfatter 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthsyre, til behandling af dermatologiske lidelser
US7569530B1 (en) 2003-06-20 2009-08-04 The Procter & Gamble Company Antimicrobial compositions, products and methods employing same
EP1515607A2 (de) * 2002-06-21 2005-03-23 The Procter & Gamble Company Antimikrobielle zusammensetzungen, produkte und verfahren unter anwendung derselben
CA2509775C (en) * 2003-01-13 2010-06-01 The Procter & Gamble Company Compositions for prevention and treatment of cold and influenza-like symptoms comprising select mucoadhesive polymers
AU2003236156A1 (en) * 2003-04-24 2005-01-04 Shin-Jen Shiao Pharmaceutical compositions used for immune disease treatment and improvement
US20050058673A1 (en) 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
CA2538760A1 (en) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. Human .beta.-defensin secretion promoter
US20050271711A1 (en) * 2004-04-26 2005-12-08 The Procter & Gamble Company Therapeutic antimicrobial compositions and methods
JP5148271B2 (ja) * 2004-06-02 2013-02-20 ニューロジズエックス，インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および／または鎮痒薬を含有する処方物
DE102004041333A1 (de) * 2004-08-20 2006-03-09 Dental-Kosmetik Gmbh & Co. Kg Zahngel
US8198326B2 (en) * 2004-09-07 2012-06-12 3M Innovative Properties Company Phenolic antiseptic compositions and methods of use
US9028852B2 (en) 2004-09-07 2015-05-12 3M Innovative Properties Company Cationic antiseptic compositions and methods of use
EP1666073B1 (de) * 2004-10-13 2008-08-27 The Procter and Gamble Company Vorrichtung zur Abgabe einer antimikrobiellen Zusammensetzung
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Company composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
BRPI0608690B8 (pt) 2005-03-10 2021-05-25 3M Innovative Properties Co uso de uma composição antimicrobiana
ITMI20052077A1 (it) * 2005-10-31 2007-05-01 Roda S R L Agente batteriostatica e-o battericida per preparazioni cosmetiche e-o dermofarmaceutiche e preparazioni contenenti questo agente
US20070110676A1 (en) * 2005-11-17 2007-05-17 The Procter & Gamble Company Compositions useful for prevention and treatment of common cold and influenza-like symptoms
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
CZ299143B6 (cs) * 2007-03-06 2008-04-30 Ecoton S. R. O. Dezinfekcní prostredek
GB2456528B (en) * 2008-01-16 2012-08-22 Pangaea Lab Ltd Antioxidant for use in cosmetic, medicated and pharmaceutical compositions
EP2090291B1 (de) * 2008-02-14 2011-09-14 KPSS-Kao Professional Salon Services GmbH Haarpflegemittel enthaltend PCA und PCA-Ester
CA2742285A1 (en) * 2008-10-30 2010-05-27 Ohso Clean, Inc. Antimicrobial foamable soaps
CA2742302C (en) * 2008-11-04 2018-01-02 Vymedic, Llc Antiviral supplement formulations
WO2011102395A1 (ja) * 2010-02-16 2011-08-25 味の素株式会社 ピロリドンカルボン酸またはその塩の製造方法
JP2013139391A (ja) * 2010-04-09 2013-07-18 Hokkaido Univ ウイルス感染抑制および／または感染症治療剤
US20110305651A1 (en) * 2010-06-15 2011-12-15 Conopco, Inc. D/B/A Unilever Sunless tanning compositions with nucleophile functionalized sulfonic acids
IT1400721B1 (it) * 2010-07-07 2013-06-28 Baldacci Lab Spa Composizioni a base di acido pirrolidoncarbossilico (pca) e sali metallici.
US8821839B2 (en) 2010-10-22 2014-09-02 Conopco, Inc. Compositions and methods for imparting a sunless tan with a vicinal diamine
ES2652521T3 (es) 2011-09-26 2018-02-02 Unilever N.V. Composición para el cabello
JP6100510B2 (ja) * 2011-11-16 2017-03-22 第一三共ヘルスケア株式会社 抗感冒剤
US8961942B2 (en) 2011-12-13 2015-02-24 Conopco, Inc. Sunless tanning compositions with adjuvants comprising sulfur comprising moieties
CN102560036A (zh) * 2012-01-17 2012-07-11 杭州百木表面技术有限公司 铜带退火防粘剂
CZ303941B6 (cs) * 2012-04-24 2013-07-03 Farmak Moravia, A.S. Dezinfekcní prípravek, jeho pouzití a zpusob dezinfekce
KR102076611B1 (ko) * 2012-11-08 2020-02-12 라이온 가부시키가이샤 구강용 조성물
US20150030862A1 (en) * 2013-07-26 2015-01-29 United State Gypsum Company Mold-resistant paper and gypsum panel, antimicrobial paper coating and related methods
WO2015040642A1 (en) * 2013-09-19 2015-03-26 B.B.S. S.P.A. Process for the preparation of an antibacterial polymer material for food application
RU2555358C1 (ru) * 2014-06-06 2015-07-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") Гель для душа
RU2577697C2 (ru) * 2014-12-26 2016-03-20 Анатолий Тимофеевич Корабельников Средство для избавления от полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
CA3012227C (en) 2015-01-23 2023-05-23 Biocidium Biopharmaceuticals Inc. Anti-bacterial compositions
RU2626829C2 (ru) * 2015-11-02 2017-08-02 Анатолий Тимофеевич Корабельников Средство для лечения полипов в пазухах носа и для предотвращения их повторного нарастания, а также способ его применения
JP6465820B2 (ja) * 2016-01-15 2019-02-06 安井 敦司 抗菌・抗ウイルス性組成物およびこれを含む潤滑剤
JP6689613B2 (ja) * 2016-01-29 2020-04-28 株式会社Ｃｓｌ 繊維用抗菌・抗ウイルス性組成物および繊維製品
JP6317798B2 (ja) * 2016-10-19 2018-04-25 小林製薬株式会社 インフルエンザウイルスの感染抑制剤
BR112019025551B1 (pt) 2017-06-05 2024-01-09 Verdesian Life Sciences U.S., Llc Composição de ácido piroglutâmico e um fungicida estrobilurina, método de aumento do rendimento de uma planta e formulação
CN107573271B (zh) * 2017-08-11 2020-01-14 吴文君 一种氨基酸类化合物及其杀菌组合物与应用
CN107467029B (zh) * 2017-08-11 2021-02-19 西北农林科技大学 一种氨基酸类农用组合物
US20190070219A1 (en) * 2017-09-06 2019-03-07 King Bio, Inc. Homeopathic Nasal Gel, Swab, and Spray Formulations
KR20190045050A (ko) 2018-09-07 2019-05-02 류형준 감기 개선 식품조성물
BR112021012637A2 (pt) 2018-12-28 2021-09-08 Diversey, Inc. Composições desinfetantes sinérgicas que têm eficácia e estabilidade antimicrobiana aprimoradas e métodos de uso das mesmas
WO2021191297A1 (en) * 2020-03-25 2021-09-30 Universität Basel Virucidal hand cream formulation
CN111467338B (zh) * 2020-04-07 2021-04-23 中国科学院深圳先进技术研究院 焦谷氨酸在制备预防和治疗抗新冠肺炎新型冠状病毒的药物中的应用
EP4226928A4 (de) * 2020-08-28 2024-10-02 Shigadry With Earth CO., LTD. Infektionsvorbeugungsverfahren und infektionsvorbeugungsvorrichtung
EP4250991A1 (de) * 2020-11-25 2023-10-04 Phoxbio Limited Reduktion viraler infektionen
CN112710651B (zh) * 2021-01-20 2023-10-13 浙江夸克生物科技有限公司 一种脂蛋白相关磷脂酶a2的测定试剂盒
KR20220110655A (ko) 2021-01-31 2022-08-09 (주)예스킨 코비드-19 항바이러스제 및 항바이러스제용 어주번트
KR102840063B1 (ko) 2021-01-31 2025-07-29 주식회사 케이팜스 코비드-19 항바이러스제
US12023399B2 (en) * 2021-06-30 2024-07-02 The Procter & Gamble Company Cleansing composition with pyrrolidone carboxylic acid
CN113956466B (zh) * 2021-11-05 2023-04-25 首都医科大学附属北京口腔医院 钛修饰双亲性高分子材料及其制备方法和其在制备口腔材料用修饰外泌体中的用途
KR102859468B1 (ko) * 2021-12-09 2025-09-15 가톨릭대학교 산학협력단 항균 및 항바이러스 조성물을 포함하는 세제, 포장재용 항균 및 항바이러스 조성물 및 항균 및 항바이러스 조성물을 포함하는 항균 제품
US12357551B2 (en) 2022-05-23 2025-07-15 The Procter & Gamble Company Antibacterial cleansing composition, uses and methods

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767788A (en) * 1978-08-14 1988-08-30 Sterling Drug Inc. Glutaric acid virucidal processes and compositions
JPS572690A (en) * 1980-06-05 1982-01-08 Kyowa Hakko Kogyo Co Ltd Preparation of l-proline by fermentation method
DE3431727A1 (de) * 1984-08-29 1986-03-13 Robugen GmbH Pharmazeutische Fabrik, 7300 Esslingen Nasenspray gegen schnupfen und grippe mit einem gehalt an zinkglukonat
US4738847A (en) * 1985-01-14 1988-04-19 Kimberly-Clark Corporation Multi-ply virucidal product
JPS6422804A (en) * 1987-07-16 1989-01-25 Kanebo Ltd Sterilizing solution composition for wet tissue
US5244880A (en) * 1988-11-02 1993-09-14 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Stable aqueous solutions of prymicin and pharmaceutical and cosmetic compositions containing these solutions
CA2003808C (en) * 1988-11-28 1999-11-09 Eugene Joseph Sehm Crosslinked polyacrylic acid
IE892257A1 (en) * 1989-07-13 1991-02-13 Elan Corp Anti-infective agent, process for its preparation and its¹use in therapy
FR2656523B1 (fr) * 1989-12-29 1992-05-07 Biorga Sa Labo Compositions pour l'usage cosmetique et/ou dermatologique, comprenant des pidolates metalliques.
CH683671A5 (it) * 1992-03-30 1994-04-29 Golgi Sa Uso topico di glicerofosfolipidi deacilati.
DK0662814T3 (da) * 1992-09-29 1996-12-02 Henkel Kgaa Hårbehandlingsmiddel
FR2697161B1 (fr) * 1992-10-26 1995-01-13 Jouvance Daniel Produit cosmétique à potentiel redox stabilisé.
US5508282C1 (en) * 1993-05-17 2001-01-23 Tulin Silver Jeffrey Composition and method for treating acute or chronic rhinosinusitis
JPH08133911A (ja) * 1994-11-04 1996-05-28 Senju Pharmaceut Co Ltd 抗菌組成物
DE19625982A1 (de) * 1996-06-28 1998-01-02 Wella Ag Kosmetisches Mittel zur Haarbehandlung mit Dendrimeren
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid

Also Published As

Publication number Publication date
DE60014163D1 (de) 2004-10-28
WO2001028552A2 (en) 2001-04-26
JP2003512323A (ja) 2003-04-02
ZA200202475B (en) 2003-06-27
WO2001028552A3 (en) 2001-06-14
EP1242073A2 (de) 2002-09-25
EP1225887A2 (de) 2002-07-31
AU777549B2 (en) 2004-10-21
CA2388802C (en) 2007-09-11
MXPA02003882A (es) 2002-10-23
RU2228177C2 (ru) 2004-05-10
NO20021830D0 (no) 2002-04-18
JP2003512325A (ja) 2003-04-02
TR200201048T2 (tr) 2002-08-21
WO2001028556A2 (en) 2001-04-26
HK1050475A1 (zh) 2003-06-27
PL355291A1 (en) 2004-04-05
NO20021830L (no) 2002-04-18
NZ518117A (en) 2004-03-26
WO2001028556A3 (en) 2001-10-11
CZ20021374A3 (cs) 2002-08-14
CN101711761A (zh) 2010-05-26
CA2382985A1 (en) 2001-04-26
DE60014163T2 (de) 2005-10-06
HUP0204123A2 (hu) 2003-04-28
CN1411372A (zh) 2003-04-16
EP1242073B1 (de) 2004-09-22
KR20020042729A (ko) 2002-06-05
AU8029700A (en) 2001-04-30
HUP0204123A3 (en) 2003-05-28
CA2388802A1 (en) 2001-04-26
RU2002113092A (ru) 2004-02-20
PL199782B1 (pl) 2008-10-31
ES2223601T3 (es) 2005-03-01
BR0014778A (pt) 2002-07-16
KR20020038945A (ko) 2002-05-24
CN1379667A (zh) 2002-11-13
AU1214701A (en) 2001-04-30

Similar Documents

Publication Publication Date Title
ATE276749T1 (de) Zusammensetzungen zur vorbeugung und behandlung der erkältung und grippe-artiger symptome und ihre verwendung
ATE325612T1 (de) Verwendung von hydroxyethylrutosiden zur behandlung von erkältungssymptomen, symptomen der allergischen rhinitis und atemwegsinfektionen
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
ID27787A (id) Senyawa, komposisi dan metode untuk pengobatan atau pencegahan infeksi yang disebabkan oleh virus dan penyakit-penyakit yang berkaitan
ATE392208T1 (de) Zusammensetzungen zur prävention und behandlung von erkältung und grippe-ähnlichen symptomen, die cheliertes zink enthalten
DE60134009D1 (de) Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
DE60139783D1 (de) Gen und pflanzenextrakte, wirksam zur behandlung und prävention von chlamydieninfektionen
DE60008753D1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE541565T1 (de) Topische verwendung von muskarinischen und opioiden mitteln zur behandlung von tinnitus
WO2003049674A3 (en) Method for treatment of enveloped viruses using jojoba oil esters
ATE271861T1 (de) Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen
DE60018704D1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE59710517D1 (de) Adamantanaminenderivate zur bekämpfung von viren der familie bornaviridae
DE60224004D1 (de) Verwendung von il-18 hemmern zur behandlung und/oder prävention von herzkrankheiten
DE69730214D1 (de) Zusammensetzung und verfahren zur behandlung von herpes simplex
DE60202684D1 (de) Pflanzenpräparat zur behandlung und heilung von bronchialen respiratorischen schwierigkeiten
ATE361071T1 (de) Verwendung von irbesartan zur vorbeugung oder behandlung pulmonaler hypertonie
EP4203954A4 (de) Glukosidase-inhibitoren zur behandlung und prävention von lungeninfektionen
DZ3225A1 (fr) Methode et compositions pour le traitement des maladies pulmonaires
NO20054670D0 (no) Behandling av intestinale tilstander med N-2,3,3-tetrametylbisyklo[2.2.1]-heptan-2-amid
NO20030137L (no) Fremgangsmåte for behandling av ustabil angina pectoris
WO2002083700A3 (en) Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
ATE293994T1 (de) Multivalente rekombinante antikörper zur behandlung von hrv infektionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties